Kronox Lab Sciences (BOM:544187) EBITDA: ₹408 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544187 Kronox Lab Sciences Ltd BOM:544187
43 GF Score
Price ₹188.25
! 3 Warning Signs
View Full Analysis

What is Kronox Lab Sciences EBITDA?

Kronox Lab Sciences BOM:544187 -3.51% 43 EBITDA is ₹408 Mil as of Jun. 2026. GuruFocus rates BOM:544187 with a GF Score™ of 43/100. The stock has 3 warning signs investors should review.

Kronox Lab Sciences's EBITDA for the three months ended in Jun. 2026 was ₹103 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₹408 Mil.

During the past 12 months, the average EBITDA Growth Rate of Kronox Lab Sciences was 15.00% per year. During the past 3 years, the average EBITDA Growth Rate was 18.20% per year. During the past 5 years, the average EBITDA Growth Rate was 20.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 6 years, the highest 3-Year average EBITDA Growth Rate of Kronox Lab Sciences was 24.30% per year. The lowest was 18.20% per year. And the median was 19.70% per year.

Kronox Lab Sciences's EBITDA per Share for the three months ended in Jun. 2026 was ₹2.82. Its EBITDA per share for the trailing twelve months (TTM) ended in Jun. 2026 was ₹11.09.

During the past 12 months, the average EBITDA per Share Growth Rate of Kronox Lab Sciences was 15.40% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 18.20% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 20.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 6 years, the highest 3-Year average EBITDA per Share Growth Rate of Kronox Lab Sciences was 24.30% per year. The lowest was 18.20% per year. And the median was 19.70% per year.

Kronox Lab Sciences  (BOM:544187) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Kronox Lab Sciences EBITDA Related Terms


Kronox Lab Sciences EBITDA Historical Data

* Premium members only.

The historical data trend for Kronox Lab Sciences's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kronox Lab Sciences EBITDA Chart

Kronox Lab Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBITDA
Get a 7-Day Free Trial 207.89 239.16 298.97 356.53 394.65

Kronox Lab Sciences Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.41 96.88 91.57 116.66 102.95

BOM:544187 vs LIN, SHW, ECL: EBITDA Comparison

For the Specialty Chemicals subindustry, Kronox Lab Sciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kronox Lab Sciences EV-to-EBITDA vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Kronox Lab Sciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Kronox Lab Sciences's EV-to-EBITDA falls into.


BOM:544187
43GF Score
Kronox Lab Sciences Ltd BOM:544187
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Kronox Lab Sciences's EBITDA for the fiscal year that ended in Mar. 2026 is calculated as

Kronox Lab Sciences's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Mar. 2026, Kronox Lab Sciences's EBITDA was ₹395 Mil.

Kronox Lab Sciences's EBITDA for the quarter that ended in Jun. 2026 is calculated as

Kronox Lab Sciences's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Jun. 2026, Kronox Lab Sciences's EBITDA was ₹103 Mil.

EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹408 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of ₹408 Mil mean?
Kronox Lab Sciences (BOM:544187) has a EBITDA of ₹408 Mil as of Jun. 2026. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Kronox Lab Sciences.
Is Kronox Lab Sciences' EBITDA too high?
Kronox Lab Sciences' current EBITDA is ₹408 Mil. Overall, Kronox Lab Sciences has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Kronox Lab Sciences' EBITDA compare to LIN and SHW?
Kronox Lab Sciences' EBITDA of ₹408 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Chemicals company?
A good EBITDA depends on the Chemicals industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Kronox Lab Sciences. Kronox Lab Sciences's current EBITDA is ₹408 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kronox Lab Sciences stock overvalued right now?
Kronox Lab Sciences (BOM:544187) has a current EBITDA of ₹408 Mil. The current EBITDA is ₹408 Mil. Kronox Lab Sciences' overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Kronox Lab Sciences (BOM:544187), the current EBITDA is ₹408 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kronox Lab Sciences Business Description

Other Exchanges KRONOX:India
Address Block No. 284, Village Dabhasa, Padra, Vadodara, GJ, IND, 391440
Kronox Lab Sciences Ltd manufactures High Purity Speciality Fine Chemicals for diversified end-user industries. The company's Fine inorganic Chemicals are used mainly as reacting agents and raw materials in the manufacturing of Active Pharmaceutical Ingredients; excipients in pharmaceutical formulations; reagents for scientific research and laboratory testing; ingredients in nutraceuticals formulations; process intermediates and fermenting agents in biotech applications; ingredients in agrochemical formulations; ingredients in personal care products; refining agents in metal refineries; and ingredients in animal health products, amongst others.
43GF Score

Get the complete analysis for BOM:544187

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹188.25
Price